Fluorescein Angiography Findings in Treatment-Naive Premature Infants with Retinal Vascular Immaturity and Persistent Avascular Retina

References

• Hughes S, Yang H, Chan-Ling T. Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci. 2000;41:1217–1228.
   PubMed Web of Science ®Google Scholar
• Smith LE. Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture. Investigative Ophthalmology & Visual Science. 2008;49(12):5177–5182. doi:10.1167/iovs.08-2584.
   PubMed Web of Science ®Google Scholar
• Warren CC, Young JB, Goldberg MR, Connor TB, Kassem IS, Costakos DM. Findings in persistent retinopathy of prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018;49(7):497–503. doi:10.3928/23258160-20180628-05.
   PubMed Web of Science ®Google Scholar
• Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: one-year outcome: structure and function. Arch Ophthalmol. 1990;108:(10). 1408–1416. 10.1001/archopht.1990.01070120056029.
   PubMedGoogle Scholar
• Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684–1695. doi:10.1001/archopht.121.12.1684.
   PubMedGoogle Scholar
• Hardy R, Palmer E, Schaffer D, Phelps D, Davis B, Cooper C, Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group. Outcome–based management of retinopathy of prematurity. J AAPOS. 1997;1(1):46–54. doi:10.1016/S1091-8531(97)90023-9.
   PubMedGoogle Scholar
• Gallo JE, Holmström G, Kugelberg U, Hedquist B, Lennerstrand G. Regressed retinopathy of prematurity and its sequelae in children aged 5-10 years. British J Ophthalmol. 1991;75(9):527–531. doi:10.1136/bjo.75.9.527.
   PubMed Web of Science ®Google Scholar
• Kaiser RS, Trese MT, Williams GA, Cox JMS. Adult retinopathy of prematurity: outcomes of rhegmatogenous retinal detachments and retinal tears. Ophthalmology. 2001;108(9):1647–1653. doi:10.1016/S0161-6420(01)00660-1.
   PubMed Web of Science ®Google Scholar
• Park KH, Hwang J-M, Choi MY, Yu YS, Chung H. Retinal detachment of regressed retinopathy of prematurity in children aged 2 to 15 years. Retina. 2004;24(3):368–375. doi:10.1097/00006982-200406000-00006.
   PubMed Web of Science ®Google Scholar
• Golas L, Shapiro MJ, Blair MP. Late ROP reactivation and retinal detachment in a teenager. Ophthalmic Surg Lasers Imaging Retina. 2018;49(8):625–628. doi:10.3928/23258160-20180803-11.
   PubMed Web of Science ®Google Scholar
• Ng EY, Lanigan B, O’Keefe M. Fundus fluorescein angiography in the screening for and management of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2006;43(2):85–90. doi:10.3928/0191-3913-20060301-07.
   PubMed Web of Science ®Google Scholar
• Vural A, Ekinci DY, Onur IU, Hergünsel GO, Yiğit FU. Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression. Int Ophthalmol. 2019;39(10):2267–2274. doi:10.1007/s10792-018-01064-7.
   PubMed Web of Science ®Google Scholar
• Mansukhani SA, Hutchinson AK, Neustein R, Schertzer J, Allen JC, Hubbard GB. Fluorescein angiography in retinopathy of prematurity: comparison of infants treated with bevacizumab to those with spontaneous regression. Ophthalmol Retina. 2019;3(5):436–443. doi:10.1016/j.oret.2019.01.016.
   PubMedGoogle Scholar
• Lepore D, Quinn GE, Molle F, et al. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. Ophthalmology. 2014;121(11):2212–2219. doi:10.1016/j.ophtha.2014.05.015.
   PubMed Web of Science ®Google Scholar
• Lorenz B, Stieger K, Jäger M, Mais C, Stieger S, Andrassi-Darida M. Retinal vascular development with 0.312 mg intravitreal bevacizumab to treat severe posterior retinopathy of prematurity. Retina. 2017;37(1):97–111. doi:10.1097/IAE.0000000000001126.
   PubMed Web of Science ®Google Scholar
• Hamad AE, Moinuddin O, Blair MP, et al. Late-onset retinal findings and complications in untreated retinopathy of prematurity. Ophthalmol Retina. 2020;4(6):602–612. doi:10.1016/j.oret.2019.12.015.
   PubMedGoogle Scholar
• Al-Taie R, Simkin SK, Douçet E, Dai S. Persistent avascular retina in infants with a history of type 2 retinopathy of prematurity: to treat or not to treat? J Pediatric Ophthalmol Strabismus. 2019;56(4):222–228. doi:10.3928/01913913-20190501-01.
   PubMed Web of Science ®Google Scholar
• Koç E, Baş AY, Özdek S, Ovalı F, Başmak H. Turkish Neonatal and Turkish ophthalmology societies consensus guideline on the retinopathy of prematurity. Turk Arch Pediatr/Türk Pediatri Arşivi. 2019;53(Suppl sup1):S151.doi:10.5152/TurkPediatriArs.2018.01815.
   Google Scholar
• Bayramoglu SE, Sayin N. The Effect of Intravitreal Bevacizumab Dose on Retinal Vascular Progression in Retinopathy of Prematurity. Ophthalmologica. 2022;245(2):161–172. doi:10.1159/000521070.
   PubMed Web of Science ®Google Scholar
• Bayramoglu SE, Sayin N. Inter-eye comparison of retinal vascular growth rate and angiographic findings following unilateral bevacizumab treatment. Eur J Ophthalmol. 2021;32(3):1430–1440. doi:10.1177/11206721211064019.
   PubMed Web of Science ®Google Scholar
• Blair MP, Shapiro MJ, Hartnett ME. Fluorescein angiography to estimate normal peripheral retinal nonperfusion in children. J AAPOS. 2012;16(3):234–237. doi:10.1016/j.jaapos.2011.12.157.
   PubMed Web of Science ®Google Scholar
• Lepore D, Molle F, Pagliara MM, et al. Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity. Ophthalmology. 2011;118(1):168–175. doi:10.1016/j.ophtha.2010.04.021.
   PubMed Web of Science ®Google Scholar
• Quinn GE. Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemic. Eye Brain. 2016;8:31. doi:10.2147/EB.S94436.
   PubMed Web of Science ®Google Scholar
• Bas AY, Demirel N, Koc E, Isik DU, Hirfanoglu İM, Tunc T. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. British J Ophthalmol. 2018;102(12):1711–1716. doi:10.1136/bjophthalmol-2017-311789.
   PubMed Web of Science ®Google Scholar
• Fierson WM, Chiang MF, Good W. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018; 142(6): doi: 10.1542/peds.2018-3061.
   PubMed Web of Science ®Google Scholar
• Ranchod TM, Ho LY, Drenser KA, Capone JA, Trese MT. Clinical presentation of familial exudative vitreoretinopathy. Ophthalmology. 2011;118(10):2070–2075. doi:10.1016/j.ophtha.2011.06.020.
   PubMed Web of Science ®Google Scholar
• John VJ, McClintic JI, Hess DJ, Berrocal AM. Retinopathy of prematurity versus familial exudative vitreoretinopathy: report on clinical and angiographic findings. Ophthalmic Surg Lasers Imaging Retina. 2016;47(1):14–19. doi:10.3928/23258160-20151214-02.
   PubMed Web of Science ®Google Scholar
• Kashani AH, Brown KT, Chang E, Drenser KA, Capone A, Trese MT. Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy. Ophthalmology. 2014;121(11):2220–2227. doi:10.1016/j.ophtha.2014.05.029.
   PubMed Web of Science ®Google Scholar
• Ruth A, Hutchinson AK, Hubbard GB. Late vitreous hemorrhage in patients with regressed retinopathy of prematurity. J AAPOS. 2008;12(2):181–185. doi:10.1016/j.jaapos.2007.09.008.
   PubMed Web of Science ®Google Scholar
• Gonzalez JMG, Snyder L, Blair M, Rohr A, Shapiro M, Greenwald M. Prophylactic peripheral laser and fluorescein angiography after bevacizumab for retinopathy of prematurity. Retina. 2018;38(4):764–772. doi:10.1097/IAE.0000000000001581.
   PubMed Web of Science ®Google Scholar
• Chiang MF, Quinn GE, Fielder AR, et al. International classification of retinopathy of prematurity. Ophthalmology. 2021;128(10):e51–e68.doi:10.1016/j.ophtha.2021.05.031.
   PubMed Web of Science ®Google Scholar
• Mayhew D, Mendonca V, Murthy B. A review of ASA physical status–historical perspectives and modern developments. Anaesthesia. 2019;74(3):373–379. doi:10.1111/anae.14569.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu C-H, Huang S, Chen J. Wnt Signaling in vascular eye diseases. Prog Retin Eye Res. 2019;70:110–133. doi:10.1016/j.preteyeres.2018.11.008
   PubMed Web of Science ®Google Scholar